ArticleScientific reports2025
Heart rate variability in female soccer players, before, during, and after a COVID-19 positive test.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study is to examine the impact of COVID-19 infection on heart rate variability (HRV) in female soccer players, with a focus on identifying changes in autonomic regulation before, during, and after a COVID-19 positive test. Seven elite female soccer players (age: 20.14 ± 6.41 years, height: 162.43 ± 4.32 cm, weight: 51.73 ± 5.65 kg) were included in the analysis after consistently recording their HRV during the specified period. Morning HRV measures were completed using photoplethysmography via the HRV4 training smartphone application, a validated tool for field-based monitoring, along with self-reported data. The players were tracked for at least 30 consecutive days before testing positive for COVID-19 using a polymerase chain reaction (PCR) test. They were also requested to record their HRV while they had COVID-19 until a negative PCR result was obtained. The study presents data on RMSSD, LnRMSSD and HR for the 30 days prior to COVID-19, as well as for the 3 days (day - 3), 2 days (day - 2), and 1 day (day - 1) leading up to COVID-19. Also, data for the first 5 days following a positive COVID-19 test are included. The results of this study indicated that LnRMSSD measurements were significantly lower 2 days (day - 2) and 1 day (day - 1) before the onset of COVID-19, as well as during the first four days following a positive COVID-19 test, compared to baseline. In addition, RMSSD measurements were significantly lower during the first 4 days after a positive COVID-19 test, while resting heart rate was significantly higher during the first and second days following a positive COVID-19 test, compared to baseline. Our findings suggest that reductions in LnRMSSD, reflecting decreased parasympathetic activity, may serve as early indicators of COVID-19 infection in elite female soccer players, potentially allowing for pre-symptomatic detection through daily HRV monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.